Institute of Immunology, Witten/Herdecke University, 58448, Witten, Germany.
Adv Exp Med Biol. 2011;714:173-82. doi: 10.1007/978-94-007-0782-5_9.
Cancer stem cells (CSCs) are a rare population of cancer cells exhibiting stem cell properties, such as self-renewal, differentiation and tissue restoration. Beside the initiation of the primary tumor, CSCs have also been associated with metastasis formation and cancer relapses. In the context of cancer relapses, we have recently postulated the existence of so-called recurrence CSCs (rCSCs). These specific CSC subtype will initiate relapses exhibiting an "oncogenic resistance" phenotype, which are characterized by a markedly increased malignancy concomitant with a drug resistance towards first line therapy. In the present chapter we will discuss the necessity of rCSCs as a distinct CSC subtype and that cell fusion could be one mechanism how rCSCs could originate.
癌症干细胞(CSC)是一类具有干细胞特性的罕见肿瘤细胞群体,如自我更新、分化和组织修复。除了原发性肿瘤的发生外,CSC 还与转移形成和癌症复发有关。在癌症复发的背景下,我们最近提出了所谓的复发 CSC(rCSC)的存在。这些特定的 CSC 亚型将引发表现出“致癌耐药”表型的复发,其特征是恶性程度明显增加,同时对一线治疗产生耐药性。在本章中,我们将讨论 rCSC 作为一种独特的 CSC 亚型的必要性,以及细胞融合可能是 rCSC 起源的一种机制。